Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 113-125

  Sarkar, Sayantani ^a   Mandal, Chandan ^a   Sangwan, Rajender ^b   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Govt of India   (India)

Author keywords

catenin; Chk1 Chk2; EMT; G2 M; Pancreatic adenocarcinoma; Wnt signaling

Indexed keywords

BETA CATENIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; GEMCITABINE; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; UNCLASSIFIED DRUG; UVOMORULIN; WITHANOLIDE; WITHANOLIDE D; WNT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WITHANIA SOMNIFERA;

CHK1/CHK2; EMT; G2/M; PANCREATIC ADENOCARCINOMA; WNT SIGNALING; Β-CATENIN;

APOPTOSIS; BETA CATENIN; CADHERINS; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CHECKPOINT KINASE 2; FLOW CYTOMETRY; G2 PHASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PANCREATIC NEOPLASMS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; WITHANOLIDES; WNT SIGNALING PATHWAY;

EID: 84893598939     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0315     Document Type: Article

References (53)

1. Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, Brennan M, Cameron JL & Klimstra DS 2002 Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/β-catenin pathway. American Journal of Pathology 160 953-962. (doi:10.1016/S0002-9440(10)64917-6)
2. Al-Aynati MM, Radulovich N, Riddell RH & Tsao MS 2004 Epithelial-cadherin and β-catenin expression changes in pancreatic intraepithelial neoplasia. Clinical Cancer Research 10 1235-1240. (doi:10.1158/1078-0432.CCR-03-0087)
3. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ & Choi W 2009 Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Research 69 5820-5828. (doi:10.1158/0008-5472.CAN-08-2819)
4. Bardeesy N & Depinho RA 2002 Pancreatic cancer biology and genetics. Nature Reviews. Cancer 2 897-909. (doi:10.1038/nrc949)
5. Bhattacharya K, Samanta SK, Tripathi R, Mallick A, Chandra S, Pal BC, Shaha C & Mandal C 2010 Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochemical Pharmacology 79 361-372. (doi:10.1016/j.bcp.2009.09.007)
6. Cao D, Maitra A, Saavedra JA, Klimstra DS, Adsay NV & Hruban RH 2005 Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Modern Pathology 18 752-761. (doi:10.1038/modpathol.3800363)
7. Chaurasiya ND, Uniyal GC, Lal P, Misra L, Sangwan NS, Tuli R & Sangwan RS 2008 Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochemical Analysis 19 148-154. (doi:10.1002/pca.1029)
8. Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S & Zeillinger R 2003 Role of p53 in G2/M cell cycle arrest and apoptosis in response to γ-irradiation in ovarian carcinoma cell lines. International Journal of Oncology 22 51-57.
9. Diwanay S, Chitre D & Patwardhan B 2004 Immunoprotection by botanical drugs in cancer chemotherapy. Journal of Ethnopharmacology 90 49-55. (doi:10.1016/j.jep.2003.09.023)
10. Eastman Q & Grosschedl R 1999 Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Current Opinion in Cell Biology 11 233-240. (doi:10.1016/S0955-0674(99)80031-3)
11. Gerdes B, Ramaswamy A, Simon B, Pietsch T, Bastian D, Kersting M, Moll R & Bartsch D 1999 Analysis of β-catenin gene mutations in pancreatic tumors. Digestion 60 544-548. (doi:10.1159/000007704)
12. Gottardi CJ, Wong E & Gumbiner BM 2001 E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. Journal of Cell Biology 153 1049-1060. (doi:10.1083/jcb.153.5.1049)
13. Gumbiner BM 1996 Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84 345-357. (doi:10.1016/S0092-8674(00) 81279-9)
14. Hartwell LH & Weinert TA 1989 Checkpoints: controls that ensure the order of cell cycle events. Science 246 629-634. (doi:10.1126/science.2683079)
15. Hruban RH, Goggins M, Parsons J & Kern SE 2000 Progression model for pancreatic cancer. Clinical Cancer Research 6 2969-2972.
16. Hwang A & Muschel RJ 1998 Radiation and the G2 phase of the cell cycle. Radiation Research 150 S52-S59. (doi:10.2307/3579808)
17. Jaffee EM, Hruban RH, Canto M & Kern SE 2002 Focus on pancreas cancer. Cancer Cell 2 25-28. (doi:10.1016/S1535-6108(02)00093-4)
18. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ & Thun MJ 2005 Cancer statistics, 2005. CA: A Cancer Journal for Clinicians 55 10-30. (doi:10.3322/canjclin.55.1.10)
19. Jordan A, Hadfield JA, Lawrence NJ & Mcgown AT 1998 Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Medicinal Research Reviews 18 259-296. (doi:10.1002/(SICI)1098-1128(199807)18: 4<259::AID-MED3>3.0.CO;2-U)
20. Kamei J, Toyofuku T & Hori M 2003 Negative regulation of p21 by β-catenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochemical and Biophysical Research Communications 312 380-387. (doi:10.1016/j.bbrc.2003.10.129)
21. Karayiannakis AJ, Syrigos KN, Polychronidis A & Simopoulos C 2001 Expression patterns of α-, β- and γ-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Anticancer Research 21 4127-4134.
22. Kim K, Pang KM, Evans M & Hay ED 2000 Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Molecular Biology of the Cell 11 3509-3523. (doi:10.1091/mbc.11.10.3509)
23. King FW, Skeen J, Hay N & Shtivelman E 2004 Inhibition of Chk1 by activated PKB/Akt. Cell Cycle 3 634-637.
24. Koesters R & Von Knebel Doeberitz M 2003 The Wnt signaling pathway in solid childhood tumors. Cancer Letters 198 123-138. (doi:10.1016/S0304-3835(03) 00367-7)
25. Lee MH, Koria P, Qu J & Andreadis ST 2009 JNK phosphorylates β-catenin and regulates adherens junctions. FASEB Journal 23 3874-3883. (doi:10.1096/fj.08-117804)
26. Leung-Pineda V, Ryan CE & Piwnica-Worms H 2006 Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Molecular Biology of the Cell 26 7529-7538. (doi:10.1128/MCB.00447-06)
27. Livshits G, Kobielak A & Fuchs E 2012 Governing epidermal homeostasis by coupling cell-cell adhesion to integrin and growth factor signaling, proliferation, and apoptosis. PNAS 109 4886-4891. (doi:10.1073/pnas.1202120109)
28. Lowy AM, Knight J & Groden J 2002 Restoration of E-cadherin/β- catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis. Surgery 132 141-148. (doi:10.1067/msy.2002.125168)
29. Lowy AM, Fenoglio-Preiser C, Kim OJ, Kordich J, Gomez A, Knight J, James L & Groden J 2003 Dysregulation of β-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Annals of Surgical Oncology 10 284-290. (doi:10.1245/ASO.2003.05.003)
30. Lustig B & Behrens J 2003 The Wnt signaling pathway and its role in tumor development. Journal of Cancer Research and Clinical Oncology 129 199-221.
31. Majid S, Saini S & Dahiya R 2012 Wnt signaling pathways in urological cancers: past decades and still growing. Molecular Cancer 11 7.
32. Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS & Mandal C 2008 Withaferin A induces apoptosis by activating p38 mitogenactivated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13 1450-1464. (doi:10.1007/s10495-008-0271-0)
33. Mann J 2002 Natural products in cancer chemotherapy: past, present and future. Nature Reviews. Cancer 2 143-148. (doi:10.1038/nrc723)
34. Min Kim S, Sun CD, Park KC, Kim HG, Lee WJ & Choi SH 2006 Accumulation of β-catenin protein, mutations in exon-3 of the β-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas. Journal of Surgical Oncology 94 418-425. (doi:10.1002/jso.20509)
35. Mondal S, Mandal C, Sangwan R, Chandra S & Mandal C 2010 Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogenactivated protein kinase. Molecular Cancer 9 239. (doi:10.1186/1476-4598-9-239)
36. Mondal S, Bhattacharya K, Mallick A, Sangwan R & Mandal C 2012 Bak compensated for Bax in p53-null cells to release cytochrome c for the initiation of mitochondrial signaling during Withanolide D-induced apoptosis. PLoS ONE 7 e34277. (doi:10.1371/journal.pone.0034277)
37. Moon RT, Bowerman B, Boutros M & Perrimon N 2002 The promise and perils of Wnt signaling through β-catenin. Science 296 1644-1666. (doi:10.1126/science.1071549)
38. Newman DJ, Cragg GM & Snader KM 2000 The influence of natural products upon drug discovery. Natural Product Reports 17 215-234. (doi:10.1039/a902202c)
39. Nishimori I, Kohsaki T, Tochika N, Takeuchi T, Minakuchi T, Okabayashi T, Kobayashi M, Hanazaki K & Onishi S 2006 Non-cystic solidpseudopapillary tumor of the pancreas showing nuclear accumulation and activating gene mutation of β-catenin. Pathology International 56 707-711. (doi:10.1111/j.1440-1827. 2006.02034.x)
40. Nusse R 1999 WNT targets. Repression and activation. Trends in Genetics 15 1-3. (doi:10.1016/S0168-9525(98)01634-5)
41. Olmeda D, Castel S, Vilaro S & Cano A 2003 β-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Molecular Biology of the Cell 14 2844-2860. (doi:10.1091/mbc.E03-01-0865)
42. Orford K, Orford CC & Byers SW 1999 Exogenous expression of β-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. Journal of Cell Biology 146 855-868. (doi:10.1083/jcb.146.4.855)
43. Polakis P 2000 Wnt signaling and cancer. Genes and Development 14 1837-1851.
44. Roose J & Clevers H 1999 TCF transcription factors: molecular switches in carcinogenesis. Biochimica et Biophysica Acta 1424 M23-M37.
45. Sarkar S, Dutta D, Samanta SK, Bhattacharya K, Pal BC, Li J, Datta K, Mandal C & Mandal C 2013 Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. International Journal of Cancer 132 695-706. (doi:10.1002/ijc.27687)
46. Shtivelman E, Sussman J & Stokoe D 2002 A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Current Biology 12 919-924. (doi:10.1016/S0960-9822(02)00843-6)
47. Takizawa CG & Morgan DO 2000 Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. Current Opinion in Cell Biology 12 658-665. (doi:10.1016/S0955-0674(00)00149-6)
48. Toyoda E, Doi R, Koizumi M, Kami K, Ito D, Mori T, Fujimoto K, Nakajima S, Wada M & Imamura M 2005 Analysis of E-, N-cadherin, α-, β- and γ-catenin expression in human pancreatic carcinoma cell lines. Pancreas 30 168-173. (doi:10.1097/01.mpa.0000148514.69873.85)
49. Wang Z, Havasi A, Gall JM, Mao H, Schwartz JH & Borkan SC 2009 β-catenin promotes survival of renal epithelial cells by inhibiting Bax. Journal of the American Society of Nephrology 20 1919-1928. (doi:10.1681/ASN. 2009030253)
50. Wang Z, Ahmad A, Li Y, Azmi AS, Miele L & Sarkar FH 2011 Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Anticancer Research 31 1105-1113.
51. Winter JM, Ting AH, Vilardell F, Gallmeier E, Baylin SB, Hruban RH, Kern SE & Iacobuzio-Donahue CA 2008 Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clinical Cancer Research 14 412-418. (doi:10.1158/1078-0432. CCR-07-0487)
52. Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V, Monga DK et al. 2006 Aberrant Wnt/β-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8 279-289. (doi:10.1593/neo.05607)
53. Zhurinsky J, Shtutman M & Ben-Ze'ev A 2000 Plakoglobin and β-catenin: protein interactions, regulation and biological roles. Journal of Cell Science 113 3127-3139. Technology